Clinical Trial Update: Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar

View source ↗

Summary

This clinical trial evaluates the acceptability and therapeutic maintenance after substitution of ustekinumab with a biosimilar in Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)
• Ustekinumab biosimilar (ustekinumab)

Snippet

Sponsor: EG Labo | Conditions: Crohn Disease (CD) | Status: RECRUITING